As such, genetic variation in CACNA1D may increase the odds of developing hypertension, a condition that contributes to the occurrence of renal dysfunction after heart transplantation and which is exacerbated by CNI use (Lindenfeld et al., 2004). This evidence concerns the gene CACNA1D and Hypertension.